Filing Details
- Accession Number:
- 0001415889-25-002824
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-03 21:01:44
- Reporting Period:
- 2025-01-31
- Filing Date:
- 2025-02-03
- Accepted Time:
- 2025-02-03 21:01:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1472012 | Immunome Inc. | IMNM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | C/O Immunome, Inc. 18702 N. Creek Parkway, Suite 100 Bothell WA 98011 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-01-31 | 150,000 | $7.75 | 669,636 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The Reporting Person purchased the shares in connection with the Issuer's recently completed underwritten public offering of common stock.
Billionaire Hedge Funds
